Mast cell stabilization potential of Sitopaladi churna: An ayurvedic formulation.

Autor: Makhija IK; Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal University, Karnataka, India., Shreedhara CS, Ram HN
Jazyk: angličtina
Zdroj: Pharmacognosy research [Pharmacognosy Res] 2013 Oct; Vol. 5 (4), pp. 306-8.
DOI: 10.4103/0974-8490.118824
Abstrakt: Background: Sitopaladi churna (SPC) is a popular polyherbal ayurvedic formulation used in the treatment of allergy and respiratory diseases.
Objective: The present study was aimed to justify the classical use of antiallergic claim by performing the mast cell stabilizing activity of extracts of SPC.
Materials and Methods: The protective effect of aqueous extract and methanolic extract - of SPC against compound 48/80-induced mast cell degranulation model was carried out.
Results: Sitopaladi churna aqueous extract (SPCA) at the dose of 300 mg/kg and Sitopaladi churna methanolic extract (SPCM) at the doses of 150 and 300 mg/kg showed better protection of mast cell degranulation (65%-74%) and were comparable to the standard drug ketotifen (79%), when peritoneal mast cells were treated with compound 48/80. The protection against mast cell degranulation was significant (P < 0.0001).
Conclusion: From the above results, it has been justified that SPC can be used to treat allergic disorders.
Databáze: MEDLINE